Cargando…

Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts

This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Lang...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovács, Árpád, Kalász, Judit, Pásztor, Enikő T., Tóth, Attila, Papp, Zoltán, Dhalla, Naranjan S., Barta, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437149/
https://www.ncbi.nlm.nih.gov/pubmed/28213770
http://dx.doi.org/10.1007/s11010-017-2954-8
_version_ 1783237536535019520
author Kovács, Árpád
Kalász, Judit
Pásztor, Enikő T.
Tóth, Attila
Papp, Zoltán
Dhalla, Naranjan S.
Barta, Judit
author_facet Kovács, Árpád
Kalász, Judit
Pásztor, Enikő T.
Tóth, Attila
Papp, Zoltán
Dhalla, Naranjan S.
Barta, Judit
author_sort Kovács, Árpád
collection PubMed
description This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Langendorff method. During heart perfusion left ventricular developed pressure (LVDP), end-diastolic pressure (LVEDP), rate of pressure development (+ dP/dt), and pressure decay (-dP/dt) were registered. Control LVDP (127.4 ± 6.1 mmHg) was reduced during Ca(2+)-depletion (9.8 ± 1.3 mmHg) and Ca(2+)-paradox (12.9 ± 1.3 mmHg) with similar decline in +dP/dt and –dP/dt. LVEDP was increased in both Ca(2+)-depletion and Ca(2+)-paradox. Compared to Control, myofibrillar Ca(2+)-stimulated ATPase activity was decreased in the Ca(2+)-depletion group (12.08 ± 0.57 vs. 8.13 ± 0.19 µmol P(i)/mg protein/h), besides unvarying Mg(2+) ATPase activity, while upon Ca(2+)-paradox myofibrillar Ca(2+)-stimulated ATPase activity was decreased (12.08 ± 0.57 vs. 8.40 ± 0.22 µmol P(i)/mg protein/h), but Mg(2+) ATPase activity was increased (3.20 ± 0.25 vs. 7.21 ± 0.36 µmol P(i)/mg protein/h). In force measurements of isolated cardiomyocytes at saturating [Ca(2+)], Ca(2+)-depleted cells had lower rate constant of force redevelopment (k (tr,max), 3.85 ± 0.21) and unchanged active tension, while those in Ca(2+)-paradox produced lower active tension (12.12 ± 3.19 kN/m(2)) and k (tr,max) (3.21 ± 23) than cells of Control group (25.07 ± 3.51 and 4.61 ± 22 kN/m(2), respectively). In biochemical assays, α-myosin heavy chain and cardiac troponin T presented progressive degradation during Ca(2+)-depletion and Ca(2+)-paradox. Our results suggest that contractile impairment in Ca(2+)-paradox partially resides in deranged sarcomeric function and compromised myofibrillar ATPase activity as a result of myofilament protein degradation, such as α-myosin heavy chain and cardiac troponin T. Impaired relaxation seen in Ca(2+)-paradoxical hearts is apparently not related to titin, rather explained by the altered myofibrillar ATPase activity.
format Online
Article
Text
id pubmed-5437149
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-54371492017-06-06 Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts Kovács, Árpád Kalász, Judit Pásztor, Enikő T. Tóth, Attila Papp, Zoltán Dhalla, Naranjan S. Barta, Judit Mol Cell Biochem Article This study aimed to explore the potential contribution of myofibrils to contractile dysfunction in Ca(2+)-paradox hearts. Isolated rat hearts were perfused with Krebs–Henseleit solution (Control), followed by Ca(2+)-depletion, and then Ca(2+)-repletion after Ca(2+)-depletion (Ca(2+)-paradox) by Langendorff method. During heart perfusion left ventricular developed pressure (LVDP), end-diastolic pressure (LVEDP), rate of pressure development (+ dP/dt), and pressure decay (-dP/dt) were registered. Control LVDP (127.4 ± 6.1 mmHg) was reduced during Ca(2+)-depletion (9.8 ± 1.3 mmHg) and Ca(2+)-paradox (12.9 ± 1.3 mmHg) with similar decline in +dP/dt and –dP/dt. LVEDP was increased in both Ca(2+)-depletion and Ca(2+)-paradox. Compared to Control, myofibrillar Ca(2+)-stimulated ATPase activity was decreased in the Ca(2+)-depletion group (12.08 ± 0.57 vs. 8.13 ± 0.19 µmol P(i)/mg protein/h), besides unvarying Mg(2+) ATPase activity, while upon Ca(2+)-paradox myofibrillar Ca(2+)-stimulated ATPase activity was decreased (12.08 ± 0.57 vs. 8.40 ± 0.22 µmol P(i)/mg protein/h), but Mg(2+) ATPase activity was increased (3.20 ± 0.25 vs. 7.21 ± 0.36 µmol P(i)/mg protein/h). In force measurements of isolated cardiomyocytes at saturating [Ca(2+)], Ca(2+)-depleted cells had lower rate constant of force redevelopment (k (tr,max), 3.85 ± 0.21) and unchanged active tension, while those in Ca(2+)-paradox produced lower active tension (12.12 ± 3.19 kN/m(2)) and k (tr,max) (3.21 ± 23) than cells of Control group (25.07 ± 3.51 and 4.61 ± 22 kN/m(2), respectively). In biochemical assays, α-myosin heavy chain and cardiac troponin T presented progressive degradation during Ca(2+)-depletion and Ca(2+)-paradox. Our results suggest that contractile impairment in Ca(2+)-paradox partially resides in deranged sarcomeric function and compromised myofibrillar ATPase activity as a result of myofilament protein degradation, such as α-myosin heavy chain and cardiac troponin T. Impaired relaxation seen in Ca(2+)-paradoxical hearts is apparently not related to titin, rather explained by the altered myofibrillar ATPase activity. Springer US 2017-02-17 2017 /pmc/articles/PMC5437149/ /pubmed/28213770 http://dx.doi.org/10.1007/s11010-017-2954-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Kovács, Árpád
Kalász, Judit
Pásztor, Enikő T.
Tóth, Attila
Papp, Zoltán
Dhalla, Naranjan S.
Barta, Judit
Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title_full Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title_fullStr Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title_full_unstemmed Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title_short Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
title_sort myosin heavy chain and cardiac troponin t damage is associated with impaired myofibrillar atpase activity contributing to sarcomeric dysfunction in ca(2+)-paradox rat hearts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437149/
https://www.ncbi.nlm.nih.gov/pubmed/28213770
http://dx.doi.org/10.1007/s11010-017-2954-8
work_keys_str_mv AT kovacsarpad myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT kalaszjudit myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT pasztorenikot myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT tothattila myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT pappzoltan myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT dhallanaranjans myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts
AT bartajudit myosinheavychainandcardiactroponintdamageisassociatedwithimpairedmyofibrillaratpaseactivitycontributingtosarcomericdysfunctioninca2paradoxrathearts